Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A bankerBig Pharma will increase acquisitions in 2025 due to patent expirations of major drugs.
Daily briefing: Cheaper versions of drugs like Wegovy are on their wayLower-cost versions of weight-loss drugs on the way as patents expire.